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Abstract
Decellularisation of skeletal muscle provides a system to study the interactions of myoblasts
with muscle extracellular matrix (ECM). This study describes the efficient decellularisation
of quadriceps muscle with the retention of matrix components and the use of this matrix for
myoblast proliferation and differentiation under serum free culture conditions. Three decel-
lularisation approaches were examined; the most effective was phospholipase A2 treat-
ment, which removed cellular material while maximizing the retention of ECM components.
Decellularised muscle matrices were then solubilized and used as substrates for C2C12
mouse myoblast serum free cultures. The muscle matrix supported myoblast proliferation
and differentiation equally as well as collagen and fibronectin. Immunofluorescence analy-
ses revealed that myoblasts seeded on muscle matrix and fibronectin differentiated to form
long, well-aligned myotubes, while myoblasts seeded on collagen were less organized.
qPCR analyses showed a time dependent increase in genes involved in skeletal muscle dif-
ferentiation and suggested that muscle-derived matrix may stimulate an increased rate of
differentiation compared to collagen and fibronectin. Decellularized whole muscle three-
dimensional scaffolds also supported cell adhesion and spreading, with myoblasts aligning
along specific tracts of matrix proteins within the scaffolds. Thus, under serum free condi-
tions, intact acellular muscle matrices provided cues to direct myoblast adhesion and migra-
tion. In addition, myoblasts were shown to rapidly secrete and organise their own matrix
glycoproteins to create a localized ECMmicroenvironment. This serum free culture system
has revealed that the correct muscle ECM facilitates more rapid cell organisation and differ-
entiation than single matrix glycoprotein substrates.
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Introduction
Skeletal muscle tissue comprises 40–50% of the human body mass and is essential for body
movement, metabolism and thermoregulation. Although muscle has excellent regenerative ca-
pacity, when an injury results in a significant loss of muscle, natural repair processes are unable
to bridge the gap between the remaining segments of the skeletal muscle fibres, leading to loss
of muscle tissue and functional deficit. One approach for treating volumetric muscle loss is tis-
sue engineering, where the use of biological scaffolds composed of extracellular matrix (ECM)
derived from animal tissue is being explored. Natural ECM, secreted by resident tissue cells,
should provide the optimal physical, chemical and biological cues to support regeneration of
that tissue. Scaffolds of native ECM have been used to regenerate heart [1] and liver [2] ex vivo
and decellularized porcine small intestinal submucosa (SIS) ECM has been used in human and
animal models to reconstruct skin [3, 4], urinary bladder [5], abdominal wall defects [6, 7], ro-
tator cuff tendon [8], and load bearing skeletal muscle [9].
Decellularized skeletal muscle is an ideal source of muscle specific ECM and provides a sys-
tem to study the role of ECM in muscle regeneration. Skeletal muscle has three layers of ECM:
the endomysium surrounds individual fibres and is in intimate contact with myofibres and sat-
ellite cells, while the perimysium, and epimysium surround groups of myofibres and the entire
muscle, respectively. The ECM provides both structural support and biochemical cues that di-
rect muscle formation. Collagens I and III are the major structural proteins in skeletal muscle
ECM, whereas collagen VI is an essential component of the satellite cell niche and contributes
to the regulation of satellite cell self-renewal [10]. Laminins containing the α2 chain are located
in the skeletal muscle basement membrane and are required for myotube formation and the
prevention of apoptosis [11, 12]. Fibronectin binds collagen and laminin and contributes to
myoblast adhesion, migration and differentiation [13], as well as being involved in satellite cell
expansion via Wnt7a signaling [14]. In addition, proteoglycans, such as decorin and perlecan,
can interact with a number of different ligands via their core proteins and their glycosamino-
glycan (GAG) chains, and as a consequence have diverse functions in skeletal muscle [15]. Spe-
cifically, both perlecan and decorin are involved in myostatin signaling, and whereas perlecan
contributes to the maintenance of fast muscle fibres, decorin is involved in the proliferation
and differentiation of myogenic cells [16, 17]. The GAG chains of proteoglycans also contribute
to myogenesis by sequestering growth factors like fibroblast growth factor 2 (FGF-2) and hepa-
tocyte growth factor (HGF); both of which stimulate skeletal muscle cell proliferation and in-
hibit differentiation [15]. Thus, a decellularised muscle matrix will ideally retain collagens,
laminin, fibronectin and proteoglycans with their GAG chains.
A number of different decellularisation techniques have been investigated for muscle tissue.
Stern et al (2009) used trypsin and Triton X-100 to decellularize rat muscle. This approach effi-
ciently removed nuclear material and retained collagen but resulted in a loss of GAGs [18].
DeQuach et al (2010) used 1% sodium dodecyl sulphate (SDS) as decellularizing agent, and
demonstrated good retention of a range of matrix proteins and GAGs [19]. Recently, Gillies
et al (2011) described a method for decellularizing skeletal muscle without detergents or pro-
teolytic enzymes, which also showed good retention of a range of matrix components including
GAGs [20].
Functional analyses of scaffolds in tissue culture traditionally use fetal bovine and horse sera
as a source of growth factors. However, sera contain a diversity of ill-defined components,
which makes it difficult to assess the contribution of specific ECMmolecules contained within
decellularized tissue scaffolds. A limited number of serum free culture systems for skeletal mus-
cle cells have been developed by others, but most contain an undefined serum substitute [21].
In one case hydrophilic substrates of 3-trimethoxysilyl propyl-diethylenetriamine were used to
An Acellular Muscle Matrix Supports Myoblast Differentiation
PLOS ONE | DOI:10.1371/journal.pone.0127675 June 1, 2015 2 / 27
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
promote attachment of primary dissociated skeletal muscle cells, even though the ECM pro-
teins vitronectin, laminin and tenascin-C were included in the media [22, 23].
Here we describe a method for decellularizing skeletal muscle that preserves most of the
ECMmolecules, including the proteoglycans. This decellularised skeletal muscle matrix was
solubilized and examined for its ability to support C2C12 myoblast proliferation and differenti-
ation under serum free culture conditions. The serum-free medium used was one that we de-
veloped specifically for C2C12 cell growth and differentiation on fibronectin substrates, and
enabled us to assess the affect of the ECM on myoblast proliferation and differentiation in the
absence of the confounding variables present in serum. The present study indicated that the
complex muscle matrix supported myoblast differentiation, with differentiation occurring ear-
lier on this matrix than on collagen I to result in the formation of well aligned myotubes.
Under serum free conditions the myoblasts secreted and organised their own ECM when
placed on a substrate and this endogenous matrix will also contribute to the myoblast’s local
microenvironment. On 3D muscle matrices, in serum-free conditions, C2C12 cells aligned and
orientated in patterns corresponding to the structure of the underlying muscle matrix. This
suggests that although “generalised” ECM scaffolds can assist in muscle repair, the correct
muscle ECMmay facilitate better cell organisation and differentiation.
Materials and Methods
Muscle sampling & ethics
Female C57Bl/6J mice aged 3 months were obtained from the Animal Resource Centre (Perth,
Australia) and were acclimated for one week following delivery. All procedures were carried
out in strict accordance with the guidelines of the National Health and Medical Research
Council of Australia and were approved by the Curtin Animal Ethics Committee (AEC 2011-
73A). Mice were anesthetized with 2% isoflurane and euthanized by cervical dislocation. Rats
euthanized by intraperitoneal overdose (50 mg/100 g body weight) of pentobarbitone sodium
(Lethabarb) were obtained from Dr Christine Cooper, Curtin University. Following euthanasia,
quadriceps muscles from both legs of the mice and rats were removed. Muscles were either
snap frozen in liquid nitrogen, or embedded for cryosectioning and frozen using isopentane
cooled with liquid nitrogen. All samples were stored at -80°C.
Decellularization of skeletal muscle sections
10 μm thick frozen sections were cut using a cryostat, mounted on silanated glass slides (ProS-
citech, Thuringowa, Australia) and decellularized using either trypsin, SDS or phospholipase
A2 (PLA2) (all from Sigma Aldrich, St Louis, MO). For the trypsin method [18], muscle sec-
tions were rinsed in PBS for 2 h and incubated in 0.05% trypsin for 20 min before the trypsin
was inhibited by Dulbecco’s modified Eagle’s medium (DMEM)(Life Technologies, Carlsbad,
CA) containing 10% fetal bovine serum (FBS) (HyClone, Thermo Scientific, Waltham, MA)
for 1 h. Sections were then washed in PBS/1% Triton X-100 for 30 min and PBS for 1 h. SDS-
based decellularisation was performed by rinsing muscle sections in distilled water for 2 h be-
fore treatment with 0.2% SDS in PBS/50 mM EDTA and 1 x cOmplete protease inhibitor
(Roche, Mannheim, Germany) for 75 min at 4°C with buffer being replaced every 20 min. Sec-
tions were then washed with 2 M NaCl/50 mM EDTA/1x protease inhibitors/20 mM Tris, pH
7.4 for 10 min at 4°C followed by 100 mMNaCl/20 mM Tris for 1 h at 4°C. Finally they were
washed twice, for 30 min, with 20 mM Tris/0.15M NaCl buffer. For the PLA2 method [24]
muscle sections were rinsed in PBS for 30 min and incubated in a phospholipase A2 (PLA2 170
U/ml), 0.5% sodium deoxycholate solution in 20 mM Tris buffer (pH 8.0)/0.15M NaCl con-
taining 1x cOmplete protease inhibitor for 30 min. Sections were washed in 3.4 M NaCl/20mM
An Acellular Muscle Matrix Supports Myoblast Differentiation
PLOS ONE | DOI:10.1371/journal.pone.0127675 June 1, 2015 3 / 27
Tris for 2 h, washed twice in PBS for 5 min, treated with DNaseI (75 U/ml) (Promega,
Madison, WI) in 1x DNase I reaction buffer (40 mM Tris-HCl pH 8.0, 10 mMMgSO4 and 1.0
mM CaCl2) for 1 h at 37°C and then washed 3x in PBS for 15 min each. Unless otherwise stat-
ed, all chemicals and solutions used in these processes were purchased from Sigma Aldrich.
DNA in muscle sections was visualized using Vectashield mounting medium containing
4’,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame, CA) and images
were captured using a Zeiss Axioskop fluorescent microscope (Carl Zeiss, Oberkochen, Ger-
many) and Spot Advanced software (SPOT Imaging solutions, Sterling Heights, MI).
Immunohistochemistry—muscle sections
Frozen muscle sections (10 μm) were thawed and fixed in 4% paraformaldehyde/PBS for
10 min and blocked in 10% FBS/1% bovine serum albumin (BSA) in PBS (blocking solution)
overnight at 4°C. Sections were washed 3 times with PBS and incubated for 2 h in primary anti-
body (Table 1) diluted in blocking solution, before being washed with PBS and incubated in
secondary antibody (Table 2) diluted in blocking solution. Sections were then washed and
mounted in Vectashield. Images were captured with a Zeiss Axioskop fluorescent microscope
using Spot Advanced software. Images were acquired at the same gain and exposure settings
and were processed using the same contrast and brightness settings. The blocking solution for
anti-decorin antibody was 10% normal donkey serum in PBS. The isotype control antibodies
were rat IgG2a, mouse IgG, rabbit IgG (all from, Life Technologies), and sheep IgG (Jackson
ImmunoResearch).
Whole muscle decellularization and solubilisation of skeletal muscle
ECM
Rat tissue was used for whole muscle decellularization to obtain sufficient material for myoblast
culture studies. Muscle was sliced into 0.5 mm pieces and rinsed in PBS containing 1x cOm-
plete protease inhibitor (Roche) for 2 h at 4°C. Muscle pieces were then treated with PLA2 (170
U/ml) 0.5% sodium deoxycholate in 20 mM Tris buffer (pH 8.0)/0.15M NaCl containing the
protease inhibitor for 18 h at room temperature (RT) until transparent. Tissue samples were
washed with 3.4 M NaCl/20 mM Tris/1x protease inhibitor for 24 h at 4°C (buffer changed
every 8 h) and then rinsed in PBS for 1 h at 4°C. The samples were treated with DNAse I
(75 U/ml) in DNase I reaction buffer at 37°C for 24 h, washed in PBS for 12 h at 4°C (3 buffer
Table 1. Primary antibodies.
Antibody Species, Isotype Clonality and Source Manufacturer.
collagen type I Rabbit IgG PolyclonalAbcam
collagen type III Rabbit IgG PolyclonalAbcam
collagen type IV Rabbit IgG PolyclonalAbcam
collagen type VI Rabbit IgG PolyclonalAbcam
Fibronectin Rabbit IgG Polyclonal, Abcam
Fibronectin Mouse IgG1 Monoclonal, EP5, Santa Cruz
Laminin α2 Rat IgG1 Monoclonal, 4H8-2Abcam
Myosin heavy chain (slow) Mouse IgG Monoclonal, NOQ7.4.D, Millipore
Decorin Sheep IgG PolyclonalAbcam
Perlecan Rabbit IgG CCN-1, Polyclonal, John Whitelock [47]
EV3C3 Mouse Phage display, Toin Van Kuppevelt [48, 49]
beta-tubulin Rabbit IgG Polyclonal, Abcam
doi:10.1371/journal.pone.0127675.t001
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changes) and stored at 4°C until used. Decellularized samples for solubilisation were air-dried
then vacuum dried for 3 h (Integrated SpeedVac, Thermo Scientific) and solubilized in 0.1 M
acetic acid/20 mM EDTA for 7 days at 4°C. The protein concentration was measured using the
Pierce BCA protein assay kit (Pierce Biotechnology, Rockford, IL).
DNA quantification in whole muscles
Forty 10 μm sections of native and decellularised muscle were collected in 1.5 ml microtubes in
300 μl of PBS. DNA was extracted using the Masterpure kit (Epicentre, Madison, WI) accord-
ing to the manufacturer’s instructions. Briefly, the muscle was incubated in 600 μl of lysis solu-
tion containing 0.1 mg proteinase K (Sigma-Aldrich) at 65°C for 45 min before being cooled to
37°C and incubated with 10 ng RNase A (Epicentre) for 30 min. Samples were kept on ice for
5 min, 300 μl of MPC protein precipitation reagent was added and the mixture centrifuged at
10,000 g for 10 min at 4°C. The supernatant was collected and DNA precipitated by adding
1 ml of isopropanol and centrifuging at 10,000g for 10 min at 4°C. The pellet was rinsed in 70%
ethanol, dried and resuspended in 35 μl of TE (10 mM Tris (pH 8.0), 1 mM EDTA) buffer.
DNA was quantified using a Nanodrop Spectrophotometer (Thermo Scientific, Waltham,
MA) and electrophoresed on a 1.5% agarose gel.
SDS-PAGE andWestern blotting
Solubilised muscle extracts were separated by SDS-PAGE on a 7.5% gel, using 10 μg of collagen
I as a standard. Gels were stained with Coomassie Brilliant Blue-R 250 (Bio-Rad, Hercules,
CA), and destained in 40% methanol/10% glacial acetic acid/50% ddH2O. Gels were imaged
using a ChemiDoc MP System (BioRad).
For Western blots, solubilised muscle extracts (40 μg) were separated by SDS-PAGE on a
4–15% Mini-PROTEAN TGX gradient gel (Bio-Rad) and proteins transferred to Immobilon-P
PVDF membrane (Millipore, Billerica, MA). The membrane was blocked in 5% skimmed
milk/0.1% Tween-20/PBS overnight at 4°C and incubated in primary antibodies. Membranes
were washed in 0.1% Tween-20 in PBS (PBST) and incubated in PBST containing anti-rabbit,
anti-mouse or anti-rat HRP-conjugated secondary antibodies (dilution, 1:2000 for anti-rabbit
and 1:1000 for anti-mouse and rat). Membranes were washed, incubated in Western Lightning
Plus-ECL substrate (Perkin Elmer, Waltham, MA) for 5 min, then imaged using ChemiDoc
MP System.
Table 2. Secondary antibodies.
Name, Immunoglobulin Conjugated Manufacturer
Goat anti-mouse HRP Dako
Goat anti-rabbit HRP Dako
Rabbit anti-rat HRP Dako
Goat anti-rabbit FITC Sigma
Goat anti-rabbit Alexa-ﬂuor 488 Molecular Probes
Goat anti-rabbit Alexa-ﬂuor 546 Molecular Probes
Goat anti-rat FITC Sigma
Goat anti-mouse Alexa-ﬂuor 488 Molecular Probes
Donkey anti-sheep Dylight 549 Jackson Immunoresearch
Rabbit, anti-VSV Sigma Aldrich
doi:10.1371/journal.pone.0127675.t002
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Scanning electron microscopy
Muscle sections from mice and rats were fixed in 4% paraformaldehyde for 30 min at RT and
dehydrated in ethanol solutions of increasing concentration (30%- 100%), for 15 min per con-
centration. Muscle sections were dried at RT, mounted on aluminium stubs and sputter coated
with platinum (5 nm) using a 208HR sputter coater (Cressington, Redding, CA). Data were
collected using an EVO Scanning Electron Microscope (Carl Zeiss).
Cell culture
The murine myoblast cell line, C2C12 (ATCC, Manassas, VA) was subcultured in DMEM, Life
Technologies, Carlsbad, CA) supplemented with 10% FBS (HyClone, Thermo Scientific), 10
mMHepes, 1 mM sodium pyruvate and 2 mM glutamine (all from Life Technologies). C2C12
myoblasts were passaged at 60–70% confluency and cells less than 20 passages were used in
all experiments.
Serum-free Proliferation and Differentiation assays
Wells of a 24 well tissue culture plate (Nunc, Thermo Fisher Scientific) were coated with 10 μg/
cm2 of solubilised ECM from acellular muscle, 10 μg/cm2 of collagen I or 5 μg/cm2 of fibronec-
tin (both from Sigma-Aldrich), incubated at 37°C for 2 h, washed with PBS and sterilized
under UV light. C2C12 myoblasts (7x103 cells/well) were plated in serum free proliferation me-
dium comprising DMEM/Ham’s F10 medium (Sigma-Aldrich) in a 1:1 ratio, 50 ng/ml epider-
mal growth factor (EGF), 25 ng/ml FGF-2, 1.0 μM/ml dexamethasone, 0.12 IU/ml insulin,
1.0 μg/ml heparin and 0.5% BSA. Growth factors were from Peprotech (Rocky Hill, NJ), dexa-
methasone, insulin and BSA were from Sigma-Aldrich and heparin was from Celsus Laborato-
ries (Cincinnati, OH). Cells were maintained in serum free proliferation medium for 4 days
and then transferred to differentiation medium (DMEM/F10 (1:1) containing 50 ng/ml EGF,
25 ng/ml insulin growth factor (IGF-1, Peprotech), 1.0 μM/ml dexamethasone and 0.5% BSA).
Controls were cells grown in proliferation medium comprising DMEM/F10/10% FBS and dif-
ferentiation medium comprising DMEM/F10/2% horse serum. For proliferation assays, cells
were harvested using 0.05% trypsin/1mM EDTA and counted using a Z Series COULTER
COUNTER (Beckmann Coulter, Indianapolis, IN). Cell count data is representative of four
independent experiments.
For immunofluorescence, C2C12 cells were cultured on glass coverslips coated with colla-
gen I (10 μg/cm2), fibronectin (5 μg/cm2) or solubilized muscle matrix (10 μg/cm2). On days 4,
6 and 8 of differentiation cells were fixed in 4% paraformaldehyde/PBS, permeabilized in 0.1%
Triton X-100/PBS and blocked in 10% FBS/1% BSA/PBS (blocking solution) for 1 h at RT.
Cells were washed with PBS and incubated for 2 h in anti-slow muscle myosin heavy chain
(MyHCB) antibody, washed with PBS and incubated in Alexa Flour 488 conjugated goat anti-
mouse antibody for 1 h and washed. Antibodies were diluted in blocking solution. The samples
were mounted in a DAPI-containing mounting medium. Images were captured with Zeiss
Axioskop fluorescent microscope using Spot Advanced software. Myotube width was mea-
sured using Image J [25]. Fifty myotubes per treatment were measured from randomly selected
MyHC positive myotubes from 6 non-overlapping fields of view. Three measurements were
made along each myotube and the mean width calculated. The number of nuclei per myofibre
(50 myofibres per treatment) was assessed by manual counting.
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Etching of coverslips
Round glass coverslips (13 mm2) (Knittel Glass, Braunschweig, Germany) were stored in 100%
ethanol before etching. Coverslips were treated with etch solution (2.5M NaOH in 60% etha-
nol) for 30 min at RT. After treatment, the coverslips were washed extensively with ddH2O,
dried and sterilized under UV light.
Quantitative real time PCR (qPCR) of muscle genes
RNA was isolated from C2C12 myoblasts using the ISOLATE RNA KIT (Bioline, Alexandria,
Australia) as per the manufacturer’s instructions. RNA concentration and purity was assessed
using a Nanodrop spectrophotometer and the LabChip GX II (Perkin Elmer, Waltham, MA).
All samples had an RNA quality score (RQS) of> 8.0. Reverse transcription was performed on
300 ng of RNA using the Tetro cDNA synthesis kit (Bioline). qPCR reactions were performed
using SensiFAST SYBR Lo-Rox kit (Bioline), with triplicate reactions containing 5 μl SYBR
Green Lo-RoX Mix, 2 μl template cDNA, 1 μl forward/reverse primer (25 ng/μl) and 2 μl
RNase free H2O. Reactions were performed on a ViiA7 Real-Time PCR system (Applied Bio-
systems, Life Technology) with a fast 96-well block using the cycling conditions: denaturation
at 95°C for 2 min, 40 cycles of denaturation at 95°C for 5 sec and annealing/extension at 60°C
for 20 sec, followed by a melt step ranging from 55–95°C. Primers were selected for four refer-
ence genes and seven genes of interest (Table 3) using the PrimerBank database [26] and pur-
chased from Geneworks (Hindmarsh, Australia). Of the reference genes, ACTAB and SDHA
were found to have the most stable expression by Normfinder [27] and Bestkeeper [28] soft-
ware. Expression levels forMyf5,MYOG,MYH1,MYH3,MYH7, ACTA1 and ACTC1 were
normalized to SDHA expression values and fold change determined using 2-delta delta Ct method
with baseline expression at day 1. Mean ± SE of 4 replicates is shown. Statistical significance
was determined using a two-tailed t-test at p<0.05.
Three-dimensional cell culture
Longitudinal and transverse cut samples of acellular rat muscle were placed in wells of a 24
well plate. C2C12 cells were harvested and 1x104 cells re-suspended in 50 μl serum free medi-
um were added to scaffolds and allowed to adhere for 30 min at 37°C. Scaffolds were trans-
ferred to new wells, 1.5 ml of media was added and cells were cultured for 7 and 14 days, with
medium replaced every third day. Cells and scaffolds were stained with Kwik Diff stain
(Thermo Fisher Scientific) which stains cell nuclei red and cell membranes and
cytoplasm blue.
Click-iT EdU (Life Technologies) cell proliferation assay was performed at day 3 of prolifer-
ation and day 6 of differentiation. Half the medium was replaced by 750 μl of medium contain-
ing 20 μM EdU and incubated for 24 h. Medium was removed, the scaffolds fixed in 4%
paraformaldehyde/PBS, washed and treated with 0.5% TX-100/PBS for 10 min. Scaffolds were
washed and incubated in 100 μl of Click-iT reaction cocktail for 30 min at RT, then washed
again, incubated in DAPI/PBS (1 μg/ml) for 10 min and imaged using a Nikon A1+ confocal
microscope (Nikon, Tokyo, Japan) using NIS-Elements AR analysis version 4.10 software. Z-
stack images (69 at 2 μm steps) were taken and merged to generate a single image.
Results
Development of the decellularisation procedure
Following decellularisation of quadriceps muscle by three methods (trypsin digestion, SDS
treatment or phospholipase A2 (PLA2) treatment), DAPI staining was used to visualize DNA,
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to indicate the extent of cell removal. No DAPI staining was seen following trypsin or PLA2
treatment but staining was present after 0.2% SDS treatment (S1A Fig). In addition, DNA ex-
tracted from untreated and decellularised muscle (of equal weights before treatment) was sepa-
rated on an agarose gel and the intensity of the bands quantified. A band of genomic DNA was
visible in the control lanes and muscle decellularised by SDS treatment, but there was no DNA
in the lanes containing extracts from muscle decellularized by trypsin or PLA2 (S1B Fig). Spec-
trophotometric analysis revealed a 58%, 36% and 82% loss of DNA by the trypsin, SDS and
PLA2 methods, respectively.
Western blots for the cellular proteins myosin heavy chain (MyHCB) and β-tubulin re-
vealed two distinct bands at 220 kDa and 160 kDa for myosin and one band at 50 kDa for β-tu-
bulin in the control sample, but no bands in the decellularised sample (S1C Fig).
Immunostaining of muscle sections for collagen IV and fibronectin was also used to evaluate
ECM preservation. Comparable collagen IV immunostaining to that of the controls was ob-
tained following decellularisation regardless of the method (Fig 1a–1f). In contrast, fibronectin
epitopes were preserved in tissue treated with SDS or PLA2 (Fig 1, compare i and j; k and l) but
were virtually absent in trypsin treated sections (Fig 1, compare g and h). Collectively, these
data indicate that PLA2 treatment was the most effective of the decellularization methods tested
and this procedure was used for all subsequent experiments.
Characterization of matrix after decellularisation
Immunostaining indicated collagens I and III were well preserved in the endomysium after
PLA2 decellularisation of muscle sections, with an increase in the fluorescence intensity of
staining following decellularisation, compared with controls (Fig 2a, 2b, 2e and 2f). Strong
Table 3. Primer and gene information for qPCR.
Gene
Namea





SDHA FR TGG GGA GTG CCG TGG TGT CA TGC CCC GTA GCC CCC AGT AG NM_023281 100
ACTAB FR GTG ACG TTG ACA TCC GTA AAG A GCC GGA CTC ATC GTA CTC
C
NM_007393 145966868c1 245
TBP FR CCT TGT ACC CTT CAC CAA TGA C ACA GCC AAG ATT CAC GGT
AGA
NM_013684 172073170c2 119
GAPDH FR AGG TCG GTG TGA ACG GAT TTG TGT AGA CCA TGT AGT TGA
GGT C
NM_008084 139
MYOG FR CGA TCT CCG CTA CAG AGG C GTT GGG ACC GAA CTC CAG T NM_031189 162287254c3 137
MYF5 FR GCC TTC GGA GCA CAC AAA G TGA CCT TCT TCA GGC GTC TAC NM_008656 240120094c2 187
ACTA1 FR CCC AAA GCT AAC CGG GAG AAG GAC AGC ACC GCC TGG ATA G NM_009606 133893192c1 89
ACTC1 FR CTG GAT TCT GGC GAT GGT GTA CGG ACA ATT TCA CGT TCA
GCA
NM_009608 14192922a1 173
MYH1 FR CGG AGT CAG GTG AAT ACT CAC G GAG CAT GAG CTA AGG CAC
TCT
NM_030679 82524273c2 153
MYH3 FR ATG AGT AGC GAC ACC GAG ATG ACA AAG CAG TAG GTT TTG
GCA T
NM_001099635 153792648c1 119
MYH7 FR ACT GTC AAC ACT AAG AGG GTC A TTG GAT GAT TTG ATC TTC
CAG GG
NM_080728 18859641a1 114
aSDHA- Succinate dehydrogenase complex, subunit A; ACTAB- beta-actin; TBP- Tata binding protein; GAPDH- Glyceraldehyde-3 phosphate
dehydrogenase; MYF5- Myogenic factor 5; MYOG-Myogenin; ACTA1- Actin, alpha 1, skeletal muscle; ACTC1- Actin, alpha 1, cardiac muscle; MYH1-
Myosin heavy chain-1; MYH3- Myosin heavy chain-3; MYH7- Myosin heavy chain-7.
bBP—length in base pairs.
doi:10.1371/journal.pone.0127675.t003
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staining similar to that of intact muscle was also observed for the basement membrane compo-
nents collagen VI (Fig 2c and 2g) and laminin α2 (Fig 2d and 2h) in the decellularised muscle
sections. Following decellularization, the heparan sulphate epitope recognised by the antibody
EV3C3 was detected (Fig 2I and 2l) and immunostaining of the proteoglycans perlecan (Fig 2j
and 2m) and decorin (Fig 2k and 2n) indicated preservation of these molecules.
Solubilized ECM extracted from PLA2 decellularised muscle was resolved by SDS-PAGE.
Coomassie Blue staining revealed the ECM extract contained high molecular weight proteins
and proteins of comparable size to collagen I (Fig 3a). The lack of low molecular weight pro-
teins indicated a loss of cytoplasmic proteins following decellularization. These extracts were
analysed using Western blotting to determine if collagen I, collagen VI, laminin α2, perlecan
and fibronectin were preserved (Fig 3b). Two bands were evident on the collagen I blot, one at
~140 kDa, probably the α1 chain, and a possible trimer above 260 kDa. The collagen VI blot
had a band above 260 kDa that was similar in intensity for extracts from untreated and decellu-
larised muscle. Fibronectin was detected as a 200 kDa band, although with a lower signal in the
decellularized extract compared to the untreated extract. A high molecular weight band
(~400kDa) bound the Laminin α2 antibody in lanes of both decellularised and untreated mus-
cle extracts. Multiple bands were revealed in perlecan blots of the untreated extract, but a single
high molecular weight band was present in the decellularised extract.
Fig 1. Differential preservation of collagen IV and fibronectin in sections treated with trypsin, SDS and PLA2.Quadriceps muscle sections treated
with trypsin (b, h), SDS (d, j) and PLA2 (f, l), and untreated controls (a, c, e, g, i, k), were fixed with 4% paraformaldehyde and stained with rabbit polyclonal
antibodies against collagen IV and fibronectin followed by a goat anti-rabbit FITC conjugated secondary antibody. Nuclei are stained with DAPI (blue).
Arrows indicate nuclear material remaining after decellularisation in SDS treated samples. Scale bar—100 μm.
doi:10.1371/journal.pone.0127675.g001
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Scanning electron microscopy confirmed the overall structural integrity of the decellularised
matrices (Fig 4). Control muscle showed a hexagonal, compact fibre arrangement (Fig 4a)
while hollow cylindrical structures were evident in the decellularized samples, revealing the tu-
bular nature of the endomysial ECM (Fig 4b and 4c). Collectively, these data supported the
conclusion that the decellularised matrix prepared using PLA2 retained its integrity.
Fig 2. ECM components are preserved in PLA2 decellularisedmuscle sections.Untreated (a–d, i–k)
and PLA2 decellularised (e–h, l–n) sections were immunostained. The antibodies against collagen I (a, e),
collagen III (b, f), collagen VI (c, g) and perlecan (k, n) were rabbit polyclonals and the second antibody was
goat anti-rabbit FITC. Antibodies against laminin α2 (d, h) and decorin (j, m) were rat and sheep polyclonals
respectively, and secondary antibodies were goat anti-rat and donkey anti-sheep FITC. The mAb, EV3C3, (i,
l) recognises a heparan sulfate epitope [46] and contains a vesicular stomatitis virus Glycoprotein (VSV-G)
tag. A rabbbit anti-VSV antibody followed by goat-anti-rabbit FITC was used. Nuclei are stained with DAPI
(blue). Scale bars—100 μm for a-h, and 50 μm for i-n.
doi:10.1371/journal.pone.0127675.g002
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Proliferation and differentiation of C2C12 myoblasts on different
matrices
The murine myoblasts C2C12s were cultured on tissue culture plastic coated with collagen 1, fi-
bronectin or solubilized rat ECM in serum free medium for 7 days (Fig 5). C2C12 myoblasts
are commonly used to investigate myoblast fusion and myotube formation. Rat quadriceps ma-
trix was used for these experiments, as it was not possible to obtain sufficient matrix material
from the smaller mouse quadriceps.
In the absence of a matrix substrate, C2C12 cells clustered and adhered poorly to the tissue
culture plastic and their proliferation and differentiation was impaired (data not shown). In
contrast, C2C12 myoblasts adhered to, spread and proliferated on all matrices (Fig 5a–5f).
They proliferated at a similar rate on collagen I and fibronectin, but grew more slowly on mus-
cle matrix, with cell numbers plateauing at day 4 (Fig 5g), when they began to differentiate.
Small myotubes can be readily seen in cultures on muscle matrix at day 4 (Fig 5f), but myo-
tubes were not present in cultures on collagen I or fibronectin at this stage.
Next, the differentiation of C2C12 myoblasts cultured on the various matrix substrates was
examined. Cells were cultured in serum free proliferation medium until 90% confluent (day 4)
and then switched into serum-free differentiation medium for a further 6–8 days. Immunos-
taining with a monoclonal antibody (mAb) to MyHCB (Fig 6a–6i) revealed the myoblasts had
differentiated and fused to form myotubes on all substrates, although on collagen I the
Fig 3. SDS-PAGE andWestern blotting indicates preservation of matrix proteins. (A) After PLA2 decellularisation ECM proteins were solubilised,
resolved on a 7.5% SDS-PAGE and visualized by Coomassie Blue staining: PLA2 decellularised matrix (lane 3) and collagen 1 (lane 2). (B) Muscle extracts
(untreated and PLA2 treated) were resolved on 4–15% gradient gels and membranes were probed with antibodies against collagen I, collagen VI, fibronectin,
and perlecan (all rabbit polyclonals) and laminin α2 (rat, clone 4H8-2). Secondary antibodies were anti-rabbit or anti-rat conjugated to HRP, and blots were
visualized using ECL. C: untreated muscle extract, PLA2: decellularise muscle extract.
doi:10.1371/journal.pone.0127675.g003
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Fig 4. Structural integrity of decellularizedmuscle tissue. Scanning electron micrographs of 0.5 mm thick
rat muscle sections (a, b) and 60 μm thick murine muscle sections (c). Images are representative of five
samples. Scale bars are 10 μm (a–b) and 20 μm (c).
doi:10.1371/journal.pone.0127675.g004
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myotubes were less well aligned and more branched than on the other substrates. Myotube
width increased from day 4 to day 6 in myoblasts cultured on collagen I and muscle matrices,
while widths remained constant in myotubes formed on fibronectin over the same time period
(Fig 6j). Overall, there was no difference in myotube width between the three substrates (Fig
6j). The number of nuclei per myofibre was also similar for all three substrates (Fig 6k) and by
day 6 of differentiation, myotubes on all substrates developed striations. Striations were ob-
served in myotubes on muscle matrix at day 4 of differentiation (Fig 6g), whereas this was not
the case when C2C12 cells were grown and differentiated on collagen I or fibronectin.
Fig 5. ECM proteins support C2C12myoblast proliferation in serum free cultures. (A) Phase contrast
images show C2C12 myoblasts cultured on collagen I (a, d), fibronectin (b, e) and solubilized muscle matrix
(c, f) after 1 and 4 days in serum free culture. Scale bars are 150 μm. A section of “f” is shown at a higher
magnification (Scale bar = 200 μm). Proliferation of C2C12 cells on protein substrates in serum free medium
was assessed by a direct cell count (g). Data are mean ± SD of 4 independent experiments.
doi:10.1371/journal.pone.0127675.g005
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Fig 6. Immunofluorescent staining of mature C2C12myotubes. C2C12myoblasts were cultured for 4 and 6 days in differentiation medium on collagen I
(a–c), fibronectin (d–f) and muscle matrix (g–i), and visualized using the mouse anti-MyHCBmAb (clone NOQ7.5.4D) and goat anti-mouse AF488. Arrows
indicate striations (c, f, g and i). Nuclei are stained with DAPI (blue). Scale bars are 50 μm for a–b, d–e, g–h and g insert; and 25 μm for c, f and i. Myotube
width was measured using ImageJ software (j), values are the mean and SD of 50 myotubes.
doi:10.1371/journal.pone.0127675.g006
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Gene expression of myogenic markers in C2C12 cells
The expression of genes involved in different stages of myogenesis was assessed using qPCR.
These genes were myogenic factor 5 (Myf5) and myogenin (MYOG), both transcription factors
belonging to the myogenic regulatory factor (MRF) family; three isoforms of myosin heavy
chain (MYH1,MYH3 andMYH7); and two muscle actin isoforms (ACTA1 and ACTC1). Of
the four reference genes tested, SDHA showed the most stable expression across all conditions
and was used as the reference gene for normalization of data. Gene expression by C2C12 cells
on days 1, 4 and 8 of differentiation was assessed when C2C12 myoblasts were cultured on col-
lagen I, fibronectin and muscle matrix (Fig 7).
Myf5 showed similar levels of expression at days 1, 4 and 8 of differentiation on collagen I
(Fig 7a). On fibronectin and muscle matrix surfaces,Myf5 levels at day 8 were significantly
lower than levels at day 1 (Fig 7b and 7c).MYOGmRNA increased on muscle matrix coated
surfaces by approximately 4-fold between days 1 and 8 (Fig 7c). In contrast, on collagen I and
fibronectin coated surfaces,MYOG levels peaked at day 4 before declining. An increase in the
expression ofMYH1,MYH7 and ACTA1 was observed from differentiation day 1 to day 4, and
maintained at day 8 on all matrices.MYH3 and ACTC1, which are expressed in immature mus-
cle, increased from differentiation day 1 to day 4, before decreasing at day 8. A similar trend
was seen on all matrices (Fig 7), although the decrease inMYH3 expression was most pro-
nounced in cells on fibronectin and muscle matrix. These data, plus the fact that on muscle ma-
trixMYH1 expression did not increase from day 4 to day 8, suggests that differentiation
occurred earlier in cells cultured on muscle matrix compared to collagen I, but at about the
same time as those on fibronectin.
C2C12 cell adhesion on three dimensional (3D) muscle matrices
Decellularized 3D rat muscle was used to examine how an intact muscle matrix affected cell ad-
hesion and proliferation. Cell proliferation in serum-free cultures on 3D matrices was assessed
using a Click-iT EdU assay, which labels recently synthesized DNA with the coloured thymi-
dine analogue EdU. Many cells were proliferating at day three after seeding (Fig 8a) and the 3D
colour coded image of the muscle scaffold (Fig 8b) showed cells were distributed to a depth of
138 μm in the matrix. After 6 days of differentiation the EdU assay was repeated (Fig 8c). In
this case the nuclei were elongated and there were no proliferating cells, suggesting that differ-
entiation was occurring. Kwik Diff staining (Fig 8d and 8f) showed the myoblasts became orga-
nised on the 3D matrices and lined up either longitudinally (Fig 8d and 8e), or in circular
patterns where the ECM had been cut in transverse section (Fig 8f). The cells appeared to be
following the structure of the endomysial matrix.
C2C12 cells differentiate and secrete matrix proteins on etched glass
substrates
As C2C12 cells failed to adhere in serum-free conditions on uncoated tissue culture plastic, it
was investigated whether a non-protein surface that facilitated cell adhesion could support pro-
liferation and differentiation. Etched glass coverslips were chosen as substrates for these experi-
ments. C2C12 cells adhered, proliferated and differentiated on etched but not untreated glass
coverslips in serum-free medium (Fig 9a). Immunostaining of differentiated cells with the
MyHCB mAb revealed long multi-nucleate, striated myotubes (Fig 9a). Atomic force micros-
copy of etched and non-etched surfaces revealed the porous nanotopography of the etched sur-
face (S2 Fig). To determine if these cells were secreting their own matrices, C2C12 cells in
serum free culture were seeded onto etched glass coverslips for 3.5 hours before being fixed
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Fig 7. Quantitative Real time PCR analysis reveals muscle differentiation onmatrix proteins. qPCR
was used to assess the expression of markers (Table 3) in differentiating C2C12 cells grown in serum free
medium on collagen I (a) fibronectin (b) and solubilised muscle matrix (c) at days 1, 4 and 8 of differentiation.
Relative expression levels forMYF5,MYOG,MYH1,MYH3,MYH7, ACTA1 and ACTC1 were normalized to
the Ct value of the reference gene (SDHA) and fold change was determined using the 2-delta delta Ct method.
Day 4 and Day 8 expression levels were normalized to Day 1 and log10 transformed. Mean ± SE of 4
biological replicates are shown. Significance was determined using a two-tailed t test at P<0.05*.
doi:10.1371/journal.pone.0127675.g007
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and immunostained using antibodies against collagen I, collagen IV, fibronectin and perlecan
(Fig 9b). Extracellular fibronectin and perlecan were deposited at this very early time point sug-
gesting these proteins may assist in cell adhesion to the etched glass, but only limited staining
of collagen I and IV was evident. Matrix deposition over time was also investigated using
serum-free cultures of C2C12 cells grown on etched glass coverslips for 3 days in proliferation
media and 6 days in differentiation media. Proliferating cells deposited an organized ECM
under the cell layer (Fig 9c). In differentiating cells, collagens I and IV were distributed around
the length of the myotubes, perlecan was patchily distributed along myotube edges, whilst fi-
bronectin displayed a filamentous web-like pattern (Fig 9c).
Discussion
In this study, serum free cultures were used to examine myoblast proliferation and differentia-
tion on solubilized and 3D decellularised quadriceps muscle matrices, where the matrices have
been prepared by a method that removes cells but retains ECM components. In the serum free
system C2C12 mouse myoblasts proliferated on solubilized acellular muscle matrix substrates,
but progressed towards differentiation at a lower confluency than if they were cultured on col-
lagen I or fibronectin substrates. Gene expression data suggested a similar differentiation pat-
tern on muscle matrix and fibronectin, and the alignment of myosin expressing myotubes on
muscle matrix and fibronectin were comparable. The 3D acellular muscle matrix supported
Fig 8. Decellularised 3Dmuscle scaffolds supported proliferation andmigration of C2C12 cells. The click-iT EdU assay was performed on C2C12
myoblasts cultured for 3 days in proliferation media (proliferating cells: green, other cells: blue; scale bar 100 μm) (a), colour-coded image of the distribution
of cells in the scaffold after 3 days (b). The EdU assay was performed on cells cultured for 3 days in proliferation media and 6 days in differentiation media
(cells coloured as above; scale bar—100 μm)(c). Cells were grown for 7 days in proliferation media, stained with Kwik Diff (nuclei—red; cytoplasm and
plasmamembrane—blue) and imaged using bright field microscopy (Zeiss Axioskop), scale bar-100 μm (d–f). The arrows indicate C2C12 myoblasts
aligning on longitudinal (e) or circular (f) tracks of ECM.
doi:10.1371/journal.pone.0127675.g008
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Fig 9. Secretion and orientation of matrix proteins by C2C12 cells under serum free conditions on etched glass. (a) C2C12 cells (3500/cm2) were
seeded on un-etched and etched glass coverslips in the wells of a 12-well plate and cultured for 3 days in serum free proliferation medium. After 3 days, the
media was changed to a serum free differentiation medium and cells were cultured for another 6 days. Post differentiation, cells were fixed and stained with
anti-myosin mouse monoclonal (NOQ7.5.4D) antibody. The secondary antibody used was a goat anti-mouse alexafluor 488 antibody. Scale bar—100 μm.
(b) The expression of matrix proteins by C2C12 myoblasts was examined on etched coverslips 3.5 hours after plating and in (c) undifferentiated (day 3
proliferation) and differentiated (day 6 differentiation) cell cultures. At these time-points cells were fixed and the coverslips immunostained using antibodies
recognising perlecan, collagen I, collagen IV and fibronectin (all rabbit polyclonal antibodies.) The secondary antibody was goat anti-rabbit alexafluor 488
antibody. Nuclei are stained with DAPI (blue). Scale bar—50 μm.
doi:10.1371/journal.pone.0127675.g009
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cell growth and directed cell alignment, suggesting that in vivo, muscle ECM guides cell posi-
tioning. The serum free system used in this study ensured that undefined ECMmolecules in
the culture medium were not affecting cell behaviour, or modulating the contribution of the
matrix protein substrates to myoblast differentiation. Interestingly, plating myoblasts on a
non-protein substrate was also sufficient for adhesion, proliferation and differentiation without
serum. Under these conditions, myoblasts secreted endogenous matrix proteins very early after
plating and these proteins attached to the substrate and became well organised. Hence, provi-
sion of an exogenous matrix substrate is not essential for serum free cultures if matrix secretion
is triggered and the culture surface supports the retention of secreted matrix proteins.
An adaptation of the method developed by Wang et al. (2011) to prepare an acellular liver
matrix via perfusion [24] was found to be the best of the three methods examined for decellu-
larising quadriceps muscle while preserving the ECM. The procedure consisted of sequential
incubations of quadriceps in PLA2, sodium deoxycholate and DNase I. Although trypsin treat-
ment effectively produced an acellular matrix, fibronectin was also removed, whereas SDS
treatment did not remove DNA efficiently. In contrast, the use of PLA2 and DNase I to decellu-
larize quadriceps muscle resulted in the effective removal of cellular material, as shown by
DNA and cytoskeletal protein analyses (S1 Fig) while preserving the structure of the matrix
(Fig 4). Although agarose gel electrophoresis and DAPI staining indicated a complete loss of
DNA following PLA2 treatment, spectrophotometry indicated only an 82% reduction in nu-
cleic acids in decellularised tissue. This may be due to differences in the sensitivities of the
methodologies, as spectrophotometry is more sensitive than agarose gel electrophoresis and vi-
sualization of DAPI staining. Other studies have investigated the loss of nuclear material via
haematoxylin and eosin (H&E) or DAPI staining [18–20], with similar results to our study.
Gillies et al (2007) used a fluorescent DNA dye and showed a 95% reduction in nucleic acid
content and no H&E staining following decellulatisation, yet western blotting still indicated
that actin was present [20]. In contrast, we demonstrated a complete loss of the intracellular
proteins myosin and β-tubulin. It is probable that some intracellular material remains after all
decellularisation methods, but the amount detected depends on the method of measurement
and the decellularisation method used.
Immunostaining indicated numerous ECM glycoproteins were retained, as antibody epi-
topes for collagens type I, III, IV and VI; fibronectin; laminin α2; proteoglycans perlecan, and a
HS epitope EV3C3 were present (Figs 1 and 2). In some instances the staining intensity in-
creased in the decellularised matrix (for example, the collagens), suggesting more antigenic
sites were exposed following cell loss. Western blotting data supported the conclusion that the
PLA2 decellularization method preserved many ECM proteins (Fig 3). Western blotting for
collagens I and VI in the solubilized ECM extracts revealed intact α1 chains as well as high mo-
lecular weight collagen trimers. Evidence of intact laminin α2 chains, fibronectin monomers
and perlecan were also obtained from the Western blotting analyses, although there did appear
to be some reduction in fibronectin and perlecan. These data are consistent with those of
Wang et al (2011), who demonstrated preservation of HS chains and perlecan in addition to
collagens and fibronectin in decellularised liver prepared using PLA2 perfusion [24]. They sug-
gested the retention of collagens enabled the preservation of collagen-binding molecules like
laminins, fibronectin, and proteoglycans, and as a consequence, the cytokines and growth fac-
tors that bind these glycoproteins [24].
Overall, the PLA2 decellularisation protocol removed a high proportion of intracellular ma-
terial, while leaving most ECM proteins intact. Although DeQuach et al (2010) describe an
SDS-based decellularisation method that demonstrated good retention of matrix components
[19] we found a large amount of residual nuclear material using this approach (S1 Fig). In con-
trast, trypsin treatment (as used by Stern et al (2009)) [18] showed excellent removal of nuclear
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material but it also stripped away a number of matrix proteins. An alternative method was de-
scribed by Gillies et al (2011) [20]. They used osmotic shock to lyse skeletal muscle cells fol-
lowed by latrunculin B and high salt treatment to removed actin and myosin, and DNase
treatment to remove nucleic acid. This method showed excellent removal of DNA, but reten-
tion of actin and myosin protein fragments, and although the collagen content was consistent
with that of intact muscle, the GAG content was reduced by approximately half [20]. This
method retained the tissue architecture as scanning electron microscopy of their acellular tibia-
lis anterior muscle revealed hollow tubular extracellular matrix structures [20], resembling the
structure of our acellular quadriceps muscle revealed by the same technique.
To assess the functional attributes of our acellular quadriceps muscle matrix, the ability of
the matrix to support the proliferation and differentiation of a murine myoblast cell line,
C2C12 under serum free conditions was examined in two and three dimensional culture condi-
tions. Two groups have reported the growth and differentiation of C2C12 myoblasts on solubi-
lized skeletal muscle ECM [18, 19]. They reported enhanced proliferation and differentiation
(increased myotube size and more nuclei per myofibre) in cells cultured on decellularised mus-
cle matrix compared to collagen I. However, these studies used medium supplemented with
fetal bovine serum for proliferation and horse serum for differentiation. As serum contains an
ill-defined mixture of growth factors and soluble ECMmatrix proteins [29], sera is likely to
have introduced confounding factors. The serum free medium used here for C2C12 cell culture
enabled a comparison of solubilized muscle matrix substrates with those of purified collagen I
and fibronectin without the confounding variables introduced by serum. Purified collagen I
was used for comparison, as it is a major component of skeletal muscle ECM. Fibronectin was
used as a positive control because our previous unpublished data indicated that fibronectin was
superior to collagen I for promoting C2C12 myoblast proliferation and differentiation in
serum free media.
Under serum free conditions C2C12 myoblasts adhered to, and maintained their character-
istic stellate shape, on fibronectin, collagen I and solubilised muscle matrix substrates (Fig 5).
However, C2C12 myoblast proliferation was slower on muscle matrix and cell numbers pla-
teaued earlier than on collagen I or fibronectin, such that the cell number on the pure protein
substrates was approximately 1.5 times that on muscle matrix. This is in contrast to Stern et al
(2009) who reported increased proliferation of C2C12 myoblasts on muscle matrix compared
to collagen, albeit in the presence of serum. However, this effect was only seen at relatively high
concentrations of matrix and collagen (0.2–0.5 mg/ml), whereas at lower concentrations (0.02–
0.05 mg/ml; more similar to that used in our study) there were only small differences in prolif-
eration rate between the different matrices [18]. It is possible the slower growth and earlier pla-
teau in cell number on the muscle matrix substrate may be due to adult, muscle-specific factors
in the matrix directing cell differentiation, even though the growth factors in the medium were
designed to stimulate proliferation. However, it is important to note that we did not compare
C2C12 myoblast behaviour on matrices decellularised by the methods used by other authors,
and thus it is possible that the discrepancies between our results and others are due to the
serum free culture rather than the retention of additional ECM components. De Quach et al
(2010) also reported earlier differentiation of C2C12 myoblasts on muscle matrix compared to
purified collagen and concluded that ECM components other than collagen in the muscle ma-
trix retained biological activity and influenced C2C12 myoblast differentiation [19].
Slower proliferation may not be a disadvantage, as it allows time for the cells to organise
and align prior to differentiation. For example, Ricotti et al (2012) evaluated the proliferation
and differentiation of two myoblast cell lines on substrates of electrospun poly (hydroxybuty-
rate) (PHB) sub-micron fibers either highly oriented or randomly aligned, or films of PHB.
The myoblasts proliferated more slowly when grown on oriented nanofibres compared to
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randomly aligned nanofibres or PHB films, but differentiated to form longer myotubes ex-
pressing higher levels of the genes characteristic of a differentiated phenotype [30]. In contrast,
Tierney et al (2014) found that enhanced proliferation of satellite cells lead to larger regenerat-
ing muscle fibres in vivo [31]. They injected an inhibitor of Stat3 (a transcription factor re-
quired for myogenic differentiation) into regenerating muscle in a murine model. This led to
increased satellite cell proliferation at 3 days, returning to control proliferation levels after
5 days. An additional effect of the inhibitor was faster repair and a larger cross sectional area of
treated myofibers compared to those of non-treated controls at day 5, although this difference
was not evident at day 25 [31]. These data suggest that transient rapid proliferation may be
beneficial to regeneration. However, we found the muscle matrix appeared to regulate prolifer-
ation rather more than the pure matrix proteins, as on these latter substrates rapid proliferation
progressed for longer, giving rise to very crowded cultures prior to differentiation and
myotube formation.
In our study, C2C12 myoblasts fused to form mature myoblasts expressing MyHCB by day
4 of differentiation on collagen, fibronectin and muscle matrix. There were no significant dif-
ferences in the thickness or number of nuclei per fibre on each substrate. These findings differ
from those of DeQuach et al (2010), who reported that both myotube width and the number of
nuclei per myotube significantly increased when myoblasts were grown on skeletal muscle ma-
trix compared to collagen coated surfaces [19]. DeQuach et al (2010) used a higher concentra-
tion of muscle matrix than used in this study. However, in our system, surfaces coated with the
higher concentrations of soluble matrix used by DeQuach et al (2010) and Stern et al (2009)
were detrimental to C2C12 growth, differentiation and viability; as the consistency of the
higher protein coating impeded cell migration and cell-cell contact (data not shown).
We found the most striking difference in myotube formation was that myotubes on collagen
I were randomly oriented with many branched fibres, whereas myotubes on fibronectin and
muscle matrix were aligned in parallel with less branching. Alignment of myotubes is a pre-
requisite for functioning muscle. Others have described C2C12 cells cultured on fibronectin
substrates as elongating, aligning and fusing earlier than cells cultured on laminin and gelatin
coated substrates [32]. Vaz et al (2012) performed time-lapse imaging of C2C12 cells cultured
on fibronectin and gelatin coated surfaces and found that C2C12 cells on fibronectin coated
surfaces migrated further and with ‘directionality’, whereas cells on gelatin moved randomly
[32]. Directional migration should assist cell alignment and hence myotube formation.
The expression of genes involved in differentiation from myoblasts to myotubes was investi-
gated. Myogenic regulatory factors are transcription regulators that control muscle differentia-
tion.Myf5 is the first of these to be expressed during mouse embryogenesis and is a marker of
committed satellite cells and myoblasts, whereas,MYOG triggers the expression of myotube
specific genes [14]. In this study,Myf5 was expressed at differentiation day 1 (Fig 7), and ex-
pression remained stable in myoblasts on collagen I, but decreased by day 8 in myoblasts on
muscle-matrix and fibronectin. Brown et al (2012) found thatMyf5 decreased in C2C12 cells
during differentiation, in contrastMYOG levels increased initially but decreased as the cells
fully differentiated [33]. This is similar to our findings with C2C12 cells on fibronectin (Fig 7a
and 7b). Another study measured mRNA levels ofMyf5 andMYOG in primary porcine muscle
stem cells cultured on collagen I, laminin, fibronectin, gelatin and Matrigel [34]. In this case
the expression ofMyf5 decreased with cell differentiation regardless of substrate; butMYOG
expression in cells on Matrigel increased in a time dependent manner and was higher than in
cells cultured on the other substrates at day 5 of differentiation [34]. On muscle matrix we
foundMYOG expression in C2C12 myoblasts increased as differentiation progressed (Fig 7c).
Like solubilised muscle matrix, Matrigel is a complex mix of ECM proteins [35]. Stern et al
(2009) measured the levels of myogenin protein at day 1 and 3 of differentiation on plastic and
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ECM coated surfaces and found that myogenin levels decreased while MyHC levels increased
as the cells differentiated, and myogenin levels were higher in C2C12 cells cultured on skeletal
muscle matrix surfaces than on uncoated surfaces [18]. This mirrors our mRNA data. Interest-
inglyMYOG null (myoG-/-) myoblasts, that cannot differentiate in vivo, form myotubes as effi-
ciently as wild-type myoblasts when cultured on gelatin [36]. Possibly, the in vitro
requirements for myogenin are less stringent than in vivo, and factors in complex matrices
maintain expression of this protein further into the differentiation pathway than is usually seen
in vitro.
Myosin, the muscle contractile protein, consists of four light chains and two heavy chains.
Myosin heavy chain has different isoforms:MYH3 is an embryonic form whereasMYH1 and
MYH7 are adult isoforms;MYH1 is expressed in fast-twitch fibres andMYH7 in slow-twitch
muscle fibres [37, 38]. Cardiac actin (ACTC1) is expressed early during differentiation of skele-
tal muscle, but is down regulated as skeletal muscle alpha actin (ACTA1) is expressed [39].
ACTA1 is the major actin isoform in muscle and is a late differentiation marker [37]. The
mRNA levels forMYH3 and ACTC1 increased at day 4 of differentiation on all three surfaces,
but decreased by day 8; with the drop in expression more pronounced on muscle matrix and fi-
bronectin than on collagen I. It is thoughtMyf5 initiates the expression ofMYH3 andMyoD
enhancesMYH3 expression.MyoD is expressed slightly later thanMyf5, appearing in myo-
blasts and myocytes, but decreasing markedly in myotubes [40]. It might be expected that a de-
crease inMyf5 expression will be followed a day or two later by a corresponding decrease in
MYH3 expression. This was observed in a study of C2C12 cells [33]. Our data do not allow
such a detailed interpretation, but the expression pattern ofMyf5 andMYH3 in cells grown on
fibronectin and muscle matrix are consistent with this report [33]. An early peak inMYH3 ex-
pression was followed by a decline in human muscle myoblasts cultured on gelatin [37], which
resembles our data for cells on collagen I. The decrease in ACTC1 expression levels by day 8 on
all three surfaces is probably associated with an increased expression of other actin isoforms, a
conclusion that is supported by the expression pattern observed for ACTA1 on all substrates
(Fig 7).
Myotube maturation was indicated by the time dependent increase in expression of adult
myosin (MYH1 andMYH7) and skeletal muscle alpha actin (ACTA1) genes. The increase in
MYH1 expression at day 4 was greater on muscle matrix than on collagen I or fibronectin, sug-
gesting myotubes on muscle matrix differentiated more quickly. Like the study by Brown et al
(2012) of the expression of myosin heavy chain isoforms during C2C12 cell differentiation
[33], our data showed a temporal pattern of gene expression. The expression levels ofMYH3
and ACTC1 peaked early and then declined whereasMYH1,MYH7 and ACTA1 were express-
ed either at increasing levels at day 8 or at the same level as day 4. A difference between our
data and theirs was in the expression levels ofMYH7; they observed similar declines inMYH7
andMYH3 expression over the same period, and groupedMYH7 with the “early” expressing
isoforms [33]. From our data, groupingMYH7 with adult isoforms is appropriate and fits bet-
ter with the in vivo expression patterns of the myosin heavy chain genes. It is possible that cul-
turing C2C12 cells on matrix proteins directs gene expression to fit more closely with what
occurs in vivo.
Solubilization of ECM destroys positional information provided to cells by the location of
molecules in an intact matrix. When C2C12 cells were seeded on acellular 3D matrices in
serum-free medium (Fig 8) they lined up longitudinally, or organised into circular patterns, de-
pending on the alignment of the endomysial matrix “tubes” that surround the muscle fibres.
Thus, particular matrix proteins provided cues to direct myoblast adhesion and migration to
specific locations on the acellular matrices (Fig 8). This should be considered when using mus-
cle grafts for repair. A recent study described the lack of full functional recovery of volumetric
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muscle injuries in rats treated with muscle autografts and suggested this was because the grafts
were not aligned in accordance with the muscle fibres in the injury bed [41]. Given our data
that myoblasts align in certain ways according to matrix signals, if autografts are incorrectly
orientated then cell alignment on the graft and the muscle will not match and will hinder re-
generation of a contracting muscle. Others have used acellular muscle matrix as grafts and de-
scribe the population of these matrices by host cells that differentiate into multinucleated
myofibres [42]. Blood vessels and myofibres have been described as penetrating further into
the acellular matrix graft as time progressed [43]. We likewise saw myoblast migration into the
acellular matrices and evidence of differentiation in our ex vivo cultures.
To investigate whether matrix protein surfaces are a requirement for myoblast growth and
differentiation in serum free conditions, a non-protein surface was tested. Glass coverslips
etched with a sodium hydroxide/ethanol solution were used as a substrate because these sur-
faces readily adsorb amino acid polymers and proteins from aqueous solutions [44]. The myo-
blasts adhered, proliferated and differentiated on etched but not on un-etched glass coverslips.
Cells generally do not interact with a surface directly, but rather via proteins absorbed onto the
surface [45]. In our serum free conditions, immuno-fluorescence experiments revealed fibro-
nectin and perlecan were deposited on the substrate by the cells within 3.5 h of plating. After 3
days of proliferation, well-organized matrix substrates of collagens type I and IV, fibronectin
and perlecan were evident below the cell layer. Thus, the etched surfaces adsorbed matrix pro-
teins secreted from the myoblasts to mediate the first steps of cell adhesion, and as the cells pro-
liferated the deposited fibronectin and type IV collagen were organized into fibril networks.
These data suggest that scaffolds for muscle repair may not be restricted to matrix proteins
(e.g. collagen), and materials that trigger matrix protein secretion and adsorb these secreted
proteins could be an alternative.
We report here the use of a serum free culture system to examine myoblast proliferation
and differentiation on solubilized and 3D muscle matrices and on a non-protein surface. We
found that PLA2 treatment produced decellularised skeletal muscle retaining all the matrix pro-
teins tested. The gene expression data and the alignment of MyHCB positive myotubes indicat-
ed that two-dimensional substrates of acellular muscle matrix may be superior to substrates of
type I collagen, but comparable to fibronectin for supporting C2C12 differentiation. Further-
more, data from the 3D acellular muscle matrices indicate that particular “tracks” within natu-
ral muscle matrices favour myoblast attachment and alignment over other regions. This means
the topography of the matrix directs the location of myotube formation and in vivo probably
facilitates the organization of myotubes into functioning muscle fibres in particular locations.
In addition to the physical and chemical cues myoblasts receive from the surrounding matrix,
they also rapidly secrete their own endogenous matrix proteins such as fibronectin, collagens I
and IV and perlecan. That is, myoblasts interact with the existing matrix or surface, but also se-
crete their own matrix to create a localized microenvironment, which may contribute to myo-
tube formation. Clearly, muscle ECM is more than the sum of its individual components and
soluble muscle matrix substrates, or pure matrix proteins, are not substitutes for an intact 3D
muscle matrix.
Supporting Information
S1 Fig. Efficacy of decellularization processes as revealed by loss of DNA and cytoskeletal
proteins from skeletal muscle sections. (A) DAPI staining of 10 μm control (a–c) and decellu-
larised muscle sections (d–f) 10 μm sections. Sections were treated with trypsin (d), SDS (e) or
PLA2 (f), scale bar—100 μm. (B) Agarose gels showing genomic DNA isolated from equal
quantities of untreated muscle and muscle decellularised using trypsin, SDS or PLA2. Lane 1—
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1Kb Plus DNAmarker, Lane 2—control muscle, lane 3—decellularised muscle. (C) Untreated
and PLA2 treated muscle extracts were resolved on 4–15%Mini-PROTEAN TGX gradient gels
and probed using antibodies against intracellular proteins myosin and β-tubulin. C—untreated
muscle extract, PLA2—decellularised muscle extract.
(TIF)
S2 Fig. AFM imaging of un-etched and etched glass. Glass coverslips (13 mm x 13 mm) were
etched using NaOH and ethanol, washed and dried under a stream of nitrogen. AFM imaging
was performed using Nanoscope III a atomic force microscope with a silicon nitride tip in con-
tact mode and a long range scanner. The above images are amplitude images with a scan size of
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